Skip to main
BLCO
BLCO logo

BLCO Stock Forecast & Price Target

BLCO Analyst Ratings

Based on 15 analyst ratings
Hold
Strong Buy 13%
Buy 27%
Hold 53%
Sell 7%
Strong Sell 0%

Bulls say

Bausch & Lomb has demonstrated strong growth metrics across its business segments, with contact lens market share increasing to 10%, reflecting a 40 basis points rise year-over-year. The surgical segment reported revenues of $231 million, a year-over-year increase of approximately 13%, bolstered by a 67% surge in premium intraocular lenses. Additionally, the consumer segment achieved revenues of $476 million in Q4, marking an 8% increase year-over-year and outpacing consensus estimates, underscoring the company’s robust performance and potential for continued market expansion.

Bears say

Bausch & Lomb is projected to experience flat to low-single digit revenue growth, leading to reduced operating margin improvement and diminished earnings per share (EPS) growth, which contribute to a negative financial outlook. Key operational risks include competition from lower-cost online contact lens providers, patent challenges, and external geopolitical factors such as the Russia-Ukraine conflict, all of which may hinder revenue growth and market share. Additionally, the company's forecasted EPS for 2025 and 2026 has been lowered, reflecting concerns over its under-scaled Surgical segment and a reliance on a lower-multiple prescription business, which justifies a discount to industry peers.

BLCO has been analyzed by 15 analysts, with a consensus rating of Hold. 13% of analysts recommend a Strong Buy, 27% recommend Buy, 53% suggest Holding, 7% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Bausch + Lomb Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Bausch + Lomb Corp (BLCO) Forecast

Analysts have given BLCO a Hold based on their latest research and market trends.

According to 15 analysts, BLCO has a Hold consensus rating as of Jul 12, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $17.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $17.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Bausch + Lomb Corp (BLCO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.